BSE filing, NSE: VIPIND. Summary written from the filing by ALFA Finder's alert engine.
VIP Industries Ltd: key numbers
- Share price
- ₹251.75
- Market cap
- ₹3,576 Cr
- Revenue (annual)
- ₹1,858 Cr
- Net profit (annual)
- ₹-338.0 Cr
- P/E (TTM)
- -9.4×Sector 49.0×
- Promoter holding
- 42.35%+0.00% QoQ
- FII holding
- 4.66%Current quarter
Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.
More from VIP Industries Ltd
All →VIP Industries Other Announcement
VIP Industries Ltd filed its quarterly shareholding pattern for the period ended September 30, 2026. The filing constitutes routine regulatory compliance with no material business events.
VIP Industries Employee Stock Options
VIP Industries allotted 1,695 equity shares upon exercise of ESAR under its 2018 plan. The equity base rose to 14,20,55,391 shares, confirming routine employee incentive activity.
VIP Industries Fund Raise of ₹500 Cr
VIP Industries Ltd's board approved a fund raise of up to ₹500 Crore for FY 2026-27. The capital will support growth initiatives and working capital requirements.
- Value
- ₹500.0 Cr
VIP Industries Board Meeting Date
V.I.P. Industries will hold a board meeting on September 18, 2026, to evaluate fund-raising proposals through equity, debt, or other financial instruments.
VIP Industries Other Announcement
VIP Industries has filed its quarterly shareholding pattern for the period ending December 31, 2025.
VIP Industries Annual General Meeting
VIP Industries held its 59th Annual General Meeting on August 21, 2026, via video conferencing to transact business as per the notice.
Other board meeting date announcements
All →Patel Engineering Board Meeting Date
Patel Engineering has scheduled its Board meeting for November 5, 2026, to approve Q1 and H1 FY27 unaudited results. No financial figures or decisions are reported in this advance notice.
GKB Ophthalmics Board Meeting Date
GKB Ophthalmics scheduled its Board Meeting for November 12, 2026. The meeting will consider approving unaudited results for the September 30, 2026 quarter and half year.
Bombay Oxygen Investments Board Meeting Date
Board meeting scheduled for Nov 6, 2026 to approve Q1 and H1 FY27 unaudited results. Trading window closed for insiders Oct 1–Nov 8, 2026.
OCCL Board Meeting Date
OCCL Ltd has scheduled its Board meeting for 6 November 2026 to consider Q1 FY27 unaudited results and a possible interim dividend. The trading window for designated persons closed from 1 October 2026.
TCM Board Meeting Date
TCM Limited intimated a Board meeting for 06/11/2026 to approve Q2 FY27 results. The trading window will reopen 48 hours after the results declaration.
Mercury Laboratories Board Meeting Date
Mercury Laboratories scheduled its Board meeting for November 5, 2026, to approve Q2/H1 FY27 results. Trading window remains closed until 48 hours post-announcement.